Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

enVVeno Medical (NVNO) Free Cash Flow (2017 - 2020)

enVVeno Medical has reported Free Cash Flow over the past 4 years, most recently at -$2.6 million for Q4 2020.

  • Quarterly results put Free Cash Flow at -$2.6 million for Q4 2020, down 61.43% from a year ago — trailing twelve months through Dec 2020 was -$7.9 million (down 25.51% YoY), and the annual figure for FY2025 was -$15.6 million, up 7.72%.
  • Free Cash Flow for Q4 2020 was -$2.6 million at enVVeno Medical, down from -$2.6 million in the prior quarter.
  • Over the last five years, Free Cash Flow for NVNO hit a ceiling of -$1.2 million in Q1 2020 and a floor of -$2.6 million in Q4 2020.
  • Median Free Cash Flow over the past 4 years was -$1.5 million (2018), compared with a mean of -$1.6 million.
  • Peak annual rise in Free Cash Flow hit 22.6% in 2020, while the deepest fall reached 71.93% in 2020.
  • enVVeno Medical's Free Cash Flow stood at -$1.3 million in 2017, then fell by 13.2% to -$1.4 million in 2018, then fell by 12.93% to -$1.6 million in 2019, then tumbled by 61.43% to -$2.6 million in 2020.
  • The last three reported values for Free Cash Flow were -$2.6 million (Q4 2020), -$2.6 million (Q3 2020), and -$1.4 million (Q2 2020) per Business Quant data.